7.23
price up icon2.26%   0.16
after-market Dopo l'orario di chiusura: 6.80 -0.43 -5.95%
loading

Tenax Therapeutics Inc Borsa (TENX) Ultime notizie

pulisher
Feb 06, 2025

Leerink Partnrs Weighs in on TENX FY2029 Earnings - Defense World

Feb 06, 2025
pulisher
Feb 05, 2025

David Risinger Recommends Buy for Tenax Therapeutics Amid Promising Phase 3 Trials and Growth Potential - TipRanks

Feb 05, 2025
pulisher
Feb 04, 2025

Tenax Therapeutics (NASDAQ:TENX) Share Price Passes Above 200-Day Moving Average – What’s Next? - Defense World

Feb 04, 2025
pulisher
Feb 01, 2025

Tenax Therapeutics to Participate in the Guggenheim SMID Cap Biotech Conference - GlobeNewswire

Feb 01, 2025
pulisher
Jan 31, 2025

Exclusive: Tenax CEO to Reveal Latest Cardiovascular Drug Pipeline Updates at Major Biotech Conference - StockTitan

Jan 31, 2025
pulisher
Jan 28, 2025

Trump's Federal Spending Freeze Puts $3 Trillion In Limbo, Threatens Industries Like Clean Energy, Defense, Health Care - Benzinga

Jan 28, 2025
pulisher
Jan 24, 2025

Tenax Therapeutics (NASDAQ:TENX) Stock Price Crosses Above 200 Day Moving Average – What’s Next? - Defense World

Jan 24, 2025
pulisher
Jan 23, 2025

Tenax Therapeutics appoints new VP of Clinical Operations - MSN

Jan 23, 2025
pulisher
Jan 22, 2025

Tenax Therapeutics Appoints Gillian Andor Vice President, Clinical Operations - The Manila Times

Jan 22, 2025
pulisher
Jan 11, 2025

Analysts Set Tenax Therapeutics, Inc. (NASDAQ:TENX) Target Price at $16.00 - Defense World

Jan 11, 2025
pulisher
Jan 06, 2025

PH balance: Tenax outweighs pharmas with levosimendan heart bid - BioWorld Online

Jan 06, 2025
pulisher
Dec 24, 2024

Tenax Therapeutics (NASDAQ:TENX) Share Price Crosses Above 200-Day Moving Average – Here’s Why - Defense World

Dec 24, 2024
pulisher
Dec 19, 2024

Comparing Merus (NASDAQ:MRUS) & Tenax Therapeutics (NASDAQ:TENX) - Defense World

Dec 19, 2024
pulisher
Dec 17, 2024

Tenax Therapeutics, Inc. (NASDAQ:TENX) Receives $16.00 Consensus Target Price from Analysts - Defense World

Dec 17, 2024
pulisher
Dec 09, 2024

Tenax Therapeutics, Inc. Appoints Thomas A. McGauley as Principal Financial Officer and Principal Accounting Officer - Marketscreener.com

Dec 09, 2024
pulisher
Dec 05, 2024

Biotech Soars Following Oversubscribed $100M Private Placement Announcement - MSN

Dec 05, 2024
pulisher
Dec 05, 2024

Will Tenax Therapeutics (NASDAQ:TENX) Spend Its Cash Wisely? - Yahoo Finance

Dec 05, 2024
pulisher
Dec 05, 2024

Is Tenax Therapeutics (NASDAQ:TENX) In A Good Position To Invest In Growth? - Simply Wall St

Dec 05, 2024
pulisher
Dec 04, 2024

Tenax Therapeutics Appoints Interim CFO Thomas McGauley - TipRanks

Dec 04, 2024
pulisher
Nov 13, 2024

Tenax Therapeutics: Q3 Earnings Snapshot - New Haven Register

Nov 13, 2024
pulisher
Nov 13, 2024

Tenax Therapeutics Reports Third Quarter 2024 Financial Results and Provides a Corporate Update - The Manila Times

Nov 13, 2024
pulisher
Nov 13, 2024

Tenax Therapeutics Secures $100M Funding, Extends Runway to 2027 Despite Wider Q3 Loss | TENX Stock News - StockTitan

Nov 13, 2024
pulisher
Nov 12, 2024

Tenax Therapeutics (NASDAQ:TENX) Stock Price Passes Above 200-Day Moving Average – Here’s Why - Defense World

Nov 12, 2024
pulisher
Oct 31, 2024

Tenax Therapeutics to Present at the Guggenheim Healthcare Innovation Conference - The Manila Times

Oct 31, 2024
pulisher
Oct 31, 2024

Tenax Therapeutics expands stock incentive plan By Investing.com - Investing.com Australia

Oct 31, 2024
pulisher
Oct 30, 2024

Tenax Therapeutics expands stock incentive plan - Investing.com

Oct 30, 2024
pulisher
Oct 30, 2024

Tenax Therapeutics Expands Stock Incentive Plan - TipRanks

Oct 30, 2024
pulisher
Oct 28, 2024

Analysts Set Tenax Therapeutics, Inc. (NASDAQ:TENX) Target Price at $170.67 - Defense World

Oct 28, 2024
pulisher
Oct 28, 2024

FY2024 Earnings Estimate for TENX Issued By Leerink Partnrs - Defense World

Oct 28, 2024
pulisher
Oct 26, 2024

Tenax Therapeutics (NASDAQ:TENX) Coverage Initiated at Leerink Partners - Defense World

Oct 26, 2024
pulisher
Oct 26, 2024

Leerink Partnrs Upgrades Tenax Therapeutics (NASDAQ:TENX) to “Strong-Buy” - Defense World

Oct 26, 2024
pulisher
Oct 24, 2024

This Sempra Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - Benzinga

Oct 24, 2024
pulisher
Oct 19, 2024

Warning: TENX is at high risk of performing badly - MSN

Oct 19, 2024
pulisher
Oct 15, 2024

Guggenheim Initiates Coverage of Tenax Therapeutics (TENX) with Buy Recommendation - Nasdaq

Oct 15, 2024
pulisher
Oct 02, 2024

Tenax Therapeutics, Inc. to Post Q3 2024 Earnings of ($1.50) Per Share, William Blair Forecasts (NASDAQ:TENX) - Defense World

Oct 02, 2024
pulisher
Sep 30, 2024

William Blair Initiates Coverage of Tenax Therapeutics (TENX) with Outperform Recommendation - MSN

Sep 30, 2024
pulisher
Sep 27, 2024

SEC Form DEF 14A filed by Tenax Therapeutics Inc. - Quantisnow

Sep 27, 2024
pulisher
Sep 26, 2024

StockNews.com Initiates Coverage on Tenax Therapeutics (NASDAQ:TENX) - Defense World

Sep 26, 2024
pulisher
Sep 24, 2024

TherapeuticsMD Inc. stock underperforms Tuesday when compared to competitors - MarketWatch

Sep 24, 2024
pulisher
Sep 24, 2024

Tencent Music Entertainment Group (NYSE:TME) Shares Gap Up to $10.18 - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Tencent Music Entertainment Group Target of Unusually High Options Trading (NYSE:TME) - MarketBeat

Sep 24, 2024
pulisher
Sep 24, 2024

Farallon Capital Management LLC Buys Shares of 2,000 TransMedics Group, Inc. (NASDAQ:TMDX) - Defense World

Sep 24, 2024
pulisher
Sep 23, 2024

Tencent Music Entertainment Group (TME): Among the Worst Affordable Stocks to Buy Under $10 - Insider Monkey

Sep 23, 2024
pulisher
Sep 23, 2024

Transmedics Group Inc [TMDX] Stock sold by Insider Hassanein Waleed H for $1.32 million - Knox Daily

Sep 23, 2024
$79.95
price down icon 1.03%
$20.11
price down icon 2.71%
$347.71
price down icon 1.71%
$4.69
price down icon 6.94%
biotechnology ONC
$223.50
price down icon 2.35%
$117.61
price down icon 1.94%
Capitalizzazione:     |  Volume (24 ore):